Analytics

Articles

Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.

Week of Feb. 21, 2011: Company and People Notes: Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.

Merck Teams with Parexel; Roche CFO to Retire; and More

Week of Jan. 17, 2011: Company and People Notes: Merck Teams with Parexel; Roche CFO to Retire; and More.

Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.

Week of Jan. 3, 2011: Company and People Notes: Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.

Expert and implementation working groups harmonize more guidelines and move Q11 forward.

Inside ICH: ICH Meets in Japan to Finalize Key Documents

During the 20 months before the crisis of contaminated heparin in early 2008, the US Food and Drug Administration did not inspect any Chinese heparin firms, according to a US Government Accountability Office, (GAO) report.

GAO Evaluates FDA's Response to 2008 Heparin Crisis

Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Week of Nov. 15, 2010: Company and People Notes: Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More

Week of Nov. 8, 2010: Company and People Notes: Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More.

PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.

Week of Oct. 25, 2010: Company and People Notes: PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.

sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.

Company and People Notes: Week of Oct. 11, 2010: sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.

Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.

Drug Substance Analysis